These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9516139)

  • 1. c-kit is expressed in soft tissue sarcoma of neuroectodermic origin and its ligand prevents apoptosis of neoplastic cells.
    Ricotti E; Fagioli F; Garelli E; Linari C; Crescenzio N; Horenstein AL; Pistamiglio P; Vai S; Berger M; di Montezemolo LC; Madon E; Basso G
    Blood; 1998 Apr; 91(7):2397-405. PubMed ID: 9516139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell factor is not essential for cell survival and proliferation of soft tissue sarcoma of neuroectodermal origin.
    Ricotti E; Bertorello N; Vai S; Pagani A; Cordero Di Montezemolo L; Madon E; Basso G
    Haematologica; 1999 Oct; 84(10):879-86. PubMed ID: 10509034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell factor suppresses apoptosis in neuroblastoma cell lines.
    Timeus F; Crescenzio N; Valle P; Pistamiglio P; Piglione M; Garelli E; Ricotti E; Rocchi P; Strippoli P; Cordero di Montezemolo L; Madon E; Ramenghi U; Basso G
    Exp Hematol; 1997 Nov; 25(12):1253-60. PubMed ID: 9357969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metastatic ability of Ewing's sarcoma cells is modulated by stem cell factor and by its receptor c-kit.
    Landuzzi L; De Giovanni C; Nicoletti G; Rossi I; Ricci C; Astolfi A; Scopece L; Scotlandi K; Serra M; Bagnara GP; Nanni P; Lollini PL
    Am J Pathol; 2000 Dec; 157(6):2123-31. PubMed ID: 11106584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential use of imatinib in Ewing's Sarcoma: evidence for in vitro and in vivo activity.
    Merchant MS; Woo CW; Mackall CL; Thiele CJ
    J Natl Cancer Inst; 2002 Nov; 94(22):1673-9. PubMed ID: 12441322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of stem cell factor and c-kit in human neuroblastoma. The Children's Cancer Group.
    Cohen PS; Chan JP; Lipkunskaya M; Biedler JL; Seeger RC
    Blood; 1994 Nov; 84(10):3465-72. PubMed ID: 7524740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571.
    Vitali R; Cesi V; Nicotra MR; McDowell HP; Donfrancesco A; Mannarino O; Natali PG; RaschellĂ  G; Dominici C
    Int J Cancer; 2003 Aug; 106(2):147-52. PubMed ID: 12800187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imatinib mesylate (STI571) interference with growth of neuroectodermal tumour cell lines does not critically involve c-Kit inhibition.
    Te Kronnie G; Timeus F; Rinaldi A; Crescenzio N; Spinelli M; Rosolen A; Ricotti E; Basso G
    Int J Mol Med; 2004 Sep; 14(3):373-82. PubMed ID: 15289888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of stem cell factor and its receptor by human neuroblastoma cells and tumors.
    Beck D; Gross N; Brognara CB; Perruisseau G
    Blood; 1995 Oct; 86(8):3132-8. PubMed ID: 7579408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell factor attenuates vascular smooth muscle apoptosis and increases intimal hyperplasia after vascular injury.
    Wang CH; Verma S; Hsieh IC; Hung A; Cheng TT; Wang SY; Liu YC; Stanford WL; Weisel RD; Li RK; Cherng WJ
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):540-7. PubMed ID: 17204664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of a KIT-positive and stem cell factor-producing cell line, KTHOS, derived from human osteosarcoma.
    Hitora T; Yamamoto T; Akisue T; Marui T; Nakatani T; Kawamoto T; Nagira K; Yoshiya S; Kurosaka M
    Pathol Int; 2005 Feb; 55(2):41-7. PubMed ID: 15693848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurogenic potential of Ewing's sarcoma cells.
    Sugimoto T; Umezawa A; Hata J
    Virchows Arch; 1997 Jan; 430(1):41-6. PubMed ID: 9037314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of SCF splice variants in human melanocytes and melanoma cell lines: potential prognostic implications.
    Welker P; Schadendorf D; Artuc M; Grabbe J; Henz BM
    Br J Cancer; 2000 Apr; 82(8):1453-8. PubMed ID: 10780526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunophenotypic profile of biomarkers related to anti-apoptotic and neural development pathways in the Ewing's family of tumors (EFT) and their therapeutic implications.
    Navarro S; Giraudo P; Karseladze AI; Smirnov A; Petrovichev N; Savelov N; Alvarado-Cabrero I; Llombart-Bosch A
    Anticancer Res; 2007; 27(4B):2457-63. PubMed ID: 17695539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunostaining of the p30/32MIC2 antigen and molecular detection of EWS rearrangements for the diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumor.
    Scotlandi K; Serra M; Manara MC; Benini S; Sarti M; Maurici D; Lollini PL; Picci P; Bertoni F; Baldini N
    Hum Pathol; 1996 Apr; 27(4):408-16. PubMed ID: 8617485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological heterogeneity of Ewing's sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical support.
    Llombart-Bosch A; Machado I; Navarro S; Bertoni F; Bacchini P; Alberghini M; Karzeladze A; Savelov N; Petrov S; Alvarado-Cabrero I; Mihaila D; Terrier P; Lopez-Guerrero JA; Picci P
    Virchows Arch; 2009 Nov; 455(5):397-411. PubMed ID: 19841938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma.
    Sturla LM; Westwood G; Selby PJ; Lewis IJ; Burchill SA
    Cancer Res; 2000 Nov; 60(21):6160-70. PubMed ID: 11085540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
    Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
    J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance of Clonogenic KIT(+) Human Colon Tumor Cells Requires Secretion of Stem Cell Factor by Differentiated Tumor Cells.
    Fatrai S; van Schelven SJ; Ubink I; Govaert KM; Raats D; Koster J; Verheem A; Borel Rinkes IH; Kranenburg O
    Gastroenterology; 2015 Sep; 149(3):692-704. PubMed ID: 25962936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase C-δ-mediated recycling of active KIT in colon cancer.
    Park M; Kim WK; Song M; Park M; Kim H; Nam HJ; Baek SH; Kim H
    Clin Cancer Res; 2013 Sep; 19(18):4961-71. PubMed ID: 23881925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.